AzTrials
AzTrials

Pelvic Girdle PainNCT07037368

Impact of Delivery Mode on Coccydynia, Pelvic Girdle Pain and Rectus Diastasis in Postpartum Females

An observational study of Pelvic Girdle Pain and Rectus Diastasis, run by Superior University at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This comparative observational study investigates the impact of delivery mode vaginal delivery versus cesarean section on the prevalence and severity of three postpartum musculoskeletal complications: coccydynia, pelvic girdle pain (PGP), and rectus diastasis (RD). Read more about this study

Who is it for?
Ages 20 to 40 years, women onlyHealthy volunteers can take part
Conditions the study is for
Pelvic Girdle Pain, Rectus Diastasis
What is being tested?
Impact of Delivery Mode
How many people
73 participants
Where
1 sitePakistan
Study dates
4 Mar 2025to 30 Sep 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: This comparative observational study investigates the impact of delivery mode vaginal delivery versus cesarean section on the prevalence and severity of three postpartum musculoskeletal complications: coccydynia, pelvic girdle pain (PGP), and rectus diastasis (RD).

Who may be able to join

  • Postpartum females aged 20-40 years
  • Females who delivered via vaginal delivery or cesarean section
  • 6 weeks to 6 months postpartum period
  • Willingness to participate and provide informed consent

Who cannot join

  • Females with a history of pelvic or spinal surgery prior to pregnancy
  • Known cases of pre-existing musculoskeletal disorders (e.g., scoliosis, chronic back pain)
  • Multiple pregnancies (twins or more) in the current or previous delivery
  • Postpartum complications unrelated to delivery mode (e.g., sepsis, trauma)

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Superior University CRC

    Lahore, Punjab Province

Other trials in Pakistan

About this study

Official title: Impact of Delivery Mode on Coccydynia, Pelvic Girdle Pain and Rectus Diastasis in Postpartum Females: a Comparative Study

This comparative observational study investigates the impact of delivery mode vaginal delivery versus cesarean section on the prevalence and severity of three postpartum musculoskeletal complications: coccydynia, pelvic girdle pain (PGP), and rectus diastasis (RD). Conducted on postpartum females aged 20-40 years within 6 weeks to 6 months after childbirth, the study aims to highlight musculoskeletal outcomes often overlooked in standard postpartum care.

Read the detailed description

A total of 73 participants were selected through non-probability sampling from rehabilitation centers and home-based postpartum populations in Lahore. Pain intensity and musculoskeletal impairments were assessed using validated tools: the Visual Analog Scale (VAS) for coccydynia, Pelvic Girdle Questionnaire (PGQ) for PGP, and finger-width palpation technique for RD. The data collection involved both self-reported questionnaires and clinical assessments by trained professionals. The goal is to identify how delivery mode influences musculoskeletal health and to support the development of more tailored physiotherapy interventions and postpartum care strategies.

Being tested
Impact of Delivery Mode
Medical subject headings
Pelvic Girdle Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Impact of Delivery ModeBehavioural

    investigates the impact of delivery mode vaginal delivery versus cesarean section on the prevalence and severity of three postpartum musculoskeletal complications: coccydynia, pelvic girdle pain (PGP), and rectus diastasis (RD). Conducted on postpartum females

Study groups in NCT07037368
Study groupRoleWhat they receive
Impact of Delivery ModeNot described
Receives: Behavioral: Impact of Delivery Mode

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analog Scale

    A 10 cm horizontal line marked from 0 (no pain) to 10 (worst imaginable pain). Scoring: The participant marks a point on the line that best represents their pain intensity. The score is measured in centimeters from the "no pain" end. Higher scores indicate more severe pain.

    Measured: 6 Month

  2. Pelvic Girdle Questionnaire (PGQ)

    Contains 25 items divided into two domains: activity limitations (20 items) and symptoms (5 items).

    Scoring: Each item is rated on a 4-point scale (0 = not at all, 1 = to a small extent, 2 = to some extent, 3 = to a great extent). Scores are summed, converted into a percentage of the maximum possible score. Higher percentages reflect greater pelvic girdle pain and disability.

    Measured: 6 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2025
  2. Study start4 Mar 2025
  3. Primary completion1 Jun 2025
  4. Study completion30 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
73 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07037368
Sponsor's protocol ID
DPT/Batch-Fall20/1015
Status last verified
Jun 2025
First submitted
17 Jun 2025
Last updated
25 Jun 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Pelvic Girdle Pain and Rectus Diastasis, run by Superior University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 25 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analog Scale (time frame: 6 Month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in